A detailed history of Geode Capital Management, LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 19,128 shares of RPTX stock, worth $53,749. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,128
Previous 26,544 27.94%
Holding current value
$53,749
Previous $87,000 25.29%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.75 - $3.99 $20,394 - $29,589
-7,416 Reduced 27.94%
19,128 $65,000
Q3 2023

Nov 13, 2023

SELL
$8.16 - $13.01 $43,631 - $69,564
-5,347 Reduced 16.77%
26,544 $320,000
Q2 2023

Aug 11, 2023

BUY
$8.63 - $12.53 $46,144 - $66,997
5,347 Added 20.14%
31,891 $337,000
Q4 2022

Feb 13, 2023

BUY
$12.5 - $18.13 $64,275 - $93,224
5,142 Added 24.03%
26,544 $390,000
Q2 2020

Aug 13, 2020

BUY
$30.8 - $32.99 $659,181 - $706,051
21,402 New
21,402 $663,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $118M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.